On 2026-11-12, ADARx Pharmaceuticals, Inc. (ADRX) announced earnings per share of $-1.74 for the fiscal quarter ending 2026-09-30, missing the average analyst estimate of $-0.40.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-11-12 | 2026-09-30 | $-0.40 | $-1.74 |